Given that the APOE e4 allele has been associated with delirium (2) and the risk of having severe COVID-19 (3,4) in the general population, we hypothesized that the APOE e4 allele may be associated with an increased risk of delirium during COVID-19-related hospitalizations. This evidence concerns the gene APOE and COVID-19.